Form 4: Gossamer Bio Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4
Richard Aranda, Chief Medical Officer of Gossamer Bio, Inc., sold 4,018 shares of common stock on March 18, 2024, to cover tax obligations related to vesting restricted stock units.
Summary
- Richard Aranda, the Chief Medical Officer of Gossamer Bio, Inc., reported a transaction involving the sale of company stock.
- On March 18, 2024, Aranda sold 4,018 shares of common stock at a weighted average price of $1.3295 per share.
- The sale was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Aranda still beneficially owns 198,799 shares of Gossamer Bio, Inc. common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (stock sale for tax obligations) by an executive, which is neither particularly positive nor negative.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation for executives. The sale itself is unlikely to have a significant impact on the company's overall performance or stock valuation.
Key Dates
| Date | Description |
|---|---|
| 03/18/2024 | Date of stock sale transaction |
| 03/19/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.